Cargando…
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma
BACKGROUND: The incidence of melanoma among those of an Asian ethnicity is lower than in Caucasians; few large‐scale Asian studies that include follow‐up data have been reported. OBJECTIVES: To investigate the clinical characteristics of Japanese patients with melanoma and to evaluate the prognostic...
Autores principales: | Fujisawa, Yasuhiro, Yoshikawa, Shusuke, Minagawa, Akane, Takenouchi, Tatsuya, Yokota, Kenji, Uchi, Hiroshi, Noma, Naoki, Nakamura, Yasuhiro, Asai, Jun, Kato, Junji, Fujiwara, Susumu, Fukushima, Satoshi, Uehara, Jiro, Hoashi, Toshihiko, Kaji, Tatsuya, Fujimura, Taku, Namikawa, Kenjiro, Yoshioka, Manabu, Murao, Naoki, Ogata, Dai, Matsuyama, Kanako, Hatta, Naohito, Shibayama, Yoshitsugu, Fujiyama, Toshiharu, Ishikawa, Masashi, Yamada, Daisuke, Kishi, Akiko, Nakamura, Yoshiyuki, Shimiauchi, Takatoshi, Fujii, Kazuyasu, Fujimoto, Manabu, Ihn, Hironobu, Katoh, Norito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536943/ https://www.ncbi.nlm.nih.gov/pubmed/30932370 http://dx.doi.org/10.1002/cam4.2110 |
Ejemplares similares
-
Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study
por: Yamazaki, Naoya, et al.
Publicado: (2017) -
Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study
por: Yokota, Kenji, et al.
Publicado: (2019) -
Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
por: Koc, Altug, et al.
Publicado: (2019) -
Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma
por: Yamazaki, Naoya, et al.
Publicado: (2019) -
Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)
por: Namikawa, Kenjiro, et al.
Publicado: (2017)